DK1931310T3 - Monofasisk filmdannende sammensætning til topisk administration - Google Patents

Monofasisk filmdannende sammensætning til topisk administration

Info

Publication number
DK1931310T3
DK1931310T3 DK06779420.6T DK06779420T DK1931310T3 DK 1931310 T3 DK1931310 T3 DK 1931310T3 DK 06779420 T DK06779420 T DK 06779420T DK 1931310 T3 DK1931310 T3 DK 1931310T3
Authority
DK
Denmark
Prior art keywords
monophasic
film
forming composition
topical administration
topical
Prior art date
Application number
DK06779420.6T
Other languages
English (en)
Inventor
Marc Barry Brown
Stuart Allen Jones
Original Assignee
Medpharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medpharm Ltd filed Critical Medpharm Ltd
Application granted granted Critical
Publication of DK1931310T3 publication Critical patent/DK1931310T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK06779420.6T 2005-09-14 2006-09-14 Monofasisk filmdannende sammensætning til topisk administration DK1931310T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0518769.5A GB0518769D0 (en) 2005-09-14 2005-09-14 Topical formulations
PCT/GB2006/003408 WO2007031753A2 (en) 2005-09-14 2006-09-14 Topical film-forming monophasic formulations

Publications (1)

Publication Number Publication Date
DK1931310T3 true DK1931310T3 (da) 2012-09-17

Family

ID=35221491

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06779420.6T DK1931310T3 (da) 2005-09-14 2006-09-14 Monofasisk filmdannende sammensætning til topisk administration

Country Status (21)

Country Link
US (1) US8349297B2 (da)
EP (1) EP1931310B1 (da)
JP (2) JP5677720B2 (da)
KR (1) KR101326207B1 (da)
CN (1) CN101304730B (da)
AU (1) AU2006290487B2 (da)
BR (1) BRPI0616061A2 (da)
CA (1) CA2622624C (da)
DK (1) DK1931310T3 (da)
ES (1) ES2391782T3 (da)
GB (1) GB0518769D0 (da)
IL (1) IL190174A (da)
NO (1) NO339113B1 (da)
NZ (1) NZ567022A (da)
PL (1) PL1931310T3 (da)
PT (1) PT1931310E (da)
RU (1) RU2428970C2 (da)
SI (1) SI1931310T1 (da)
UA (1) UA94917C2 (da)
WO (1) WO2007031753A2 (da)
ZA (1) ZA200803150B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9283177B2 (en) * 2007-01-16 2016-03-15 Juventio, Llc Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic
CA2675797A1 (en) 2007-01-16 2008-07-24 Dermworx, Incorporated Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic
CA2730787A1 (en) * 2008-07-16 2010-01-21 David M. Cohen Topical drug delivery system
WO2010019953A1 (en) 2008-08-15 2010-02-18 Arcion Therapeutics, Inc. High concentration local anesthetic formulations for treating non-neuropathic pain
US20100202978A1 (en) * 2009-02-12 2010-08-12 Gurge Ronald M Foamable benzoyl peroxide compositions for topical administration
MX2012003588A (es) * 2009-09-25 2012-07-25 Pharmasol Corp Recubrimientos superficiales para la piel.
WO2011061155A1 (en) 2009-11-17 2011-05-26 Bayer Consumer Care Ag Antifungal formulations and their use
KR20150036825A (ko) * 2010-04-13 2015-04-07 나지브 바불 1-메틸-2''-6''-피페콜옥실리디드의 피부 약제학적 조성물 및 사용 방법
EP2409702A1 (en) 2010-07-21 2012-01-25 Bayer Innovation GmbH Combination of siloxane and active ingredient for treating dental disorder of hard tissues
MX2014015657A (es) 2012-07-06 2015-03-20 Leo Pharma As Composicion topica que comprende un polimero formador de pelicula para liberar un ingrediente activo a la piel.
RU2507600C1 (ru) * 2012-07-20 2014-02-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Способ и устройство для моделирования инфицированной раны слизистой оболочки полости рта в эксперименте
CN102772801B (zh) * 2012-08-10 2014-10-15 江苏长泰药业有限公司 一种用于治疗擦伤的伤口喷雾剂及其制备方法
FR3010635B1 (fr) * 2013-09-13 2017-01-20 Pf Medicament Compositions pharmaceutiques a base d'agent filmogene pour le traitement de l'hyposialie
DE102015209752A1 (de) 2015-05-28 2016-12-01 Beiersdorf Ag Sprühfähige hochviskose kosmetische Zubereitung
WO2017091739A1 (en) * 2015-11-23 2017-06-01 Grace Therapeutics Llc Topical film-forming spray
FR3064488B1 (fr) * 2017-03-31 2021-01-01 Urgo Rech Innovation Et Developpement Composition contenant un derive de cellulose, un plastifiant, un solvant volatil et un actif, ses utilisations comme pansement
AU2018378072B2 (en) 2017-12-04 2024-05-23 Kenvue Brands Llc Topical emulsion composition containing nonsteroidal anti-inflammatory drug
EP3927320A2 (en) 2019-02-19 2021-12-29 Bluepharma Indústria Farmacêutica, S.A. Mucoadhesive compositions and uses thereof
WO2023250369A2 (en) * 2022-06-21 2023-12-28 Taro Pharmaceutical Industries Ltd. Topical naftifine compositions
JP2025536556A (ja) 2022-10-25 2025-11-07 ヴェラダーミクス インコーポレイテッド 放出調節ミノキシジル用組成物および使用方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4534958A (en) * 1983-07-13 1985-08-13 Basf Wyandotte Corporation Aerosol gel
ZA859160B (en) 1984-08-29 1986-07-30 Denis Glynn Catton Dip compositions
DE3612305A1 (de) 1986-04-11 1987-10-22 Roehm Pharma Gmbh Fluessige arzneiform zur therapie der psoriasis auf basis filmbildender polymere
US4863721A (en) * 1987-05-22 1989-09-05 The Procter & Gamble Company Reduced stinging antiperspirant compositions
ATE72129T1 (de) 1987-05-27 1992-02-15 Burghart Kurt Transdermal therapeutisch wirkende pharmazeutische zubereitung sowie vorrichtung zum aufbringen der zubereitung.
JPS6450816A (en) * 1987-08-21 1989-02-27 Kanebo Ltd Isosorbide nitrate agent for transcutaneous use
US4752466A (en) 1987-08-31 1988-06-21 Johnson & Johnson Products, Inc. Thrombin aerosol
JPH01230514A (ja) * 1987-11-25 1989-09-14 Osaka Aerosol Ind Corp エアゾール型外用貼付剤
GB9021546D0 (en) * 1990-10-04 1990-11-21 Beecham Group Plc Novel composition
MX9203481A (es) 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
US6123924A (en) 1991-09-25 2000-09-26 Fisons Plc Pressurized aerosol inhalation compositions
PT731688E (pt) 1993-12-02 2003-07-31 Abbott Lab Formulacoes de farmacos em aerossol para utilizacao com propulsores sem cfc
GB9404248D0 (en) * 1994-03-05 1994-04-20 Boots Co Plc Pharmaceutical formulations
JP3881400B2 (ja) 1995-02-22 2007-02-14 久光製薬株式会社 エアゾール組成物及びエアゾール型外用製剤
FR2740038B1 (fr) 1995-10-20 1998-01-02 Lafon Labor Composition pour l'administration transdermique
JPH111433A (ja) * 1997-06-13 1999-01-06 Shionogi & Co Ltd トルナフテ−ト含有液剤
FR2787712B1 (fr) * 1998-12-24 2002-08-30 Sanofi Sa Composition cosmetique pulverisable et matrice utilisable dans cette composition pour une administration dermique
DK1150661T3 (da) 1999-02-05 2004-03-01 Cipla Ltd Topiske sprays der omfatter et filmdannende præparat
US6962691B1 (en) * 1999-05-20 2005-11-08 U & I Pharmaceuticals Ltd. Topical spray compositions
US7083781B2 (en) 1999-08-19 2006-08-01 Lavipharm S.A. Film forming polymers, methods of use, and devices and applications thereof
US6432415B1 (en) * 1999-12-17 2002-08-13 Axrix Laboratories, Inc. Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
US7820615B2 (en) * 2000-05-11 2010-10-26 Rhe Procter & Gamble Company Method of providing delayed release of a volatile solvent from hydro-alcoholic cosmetic compositions
FR2808685B1 (fr) 2000-05-12 2004-10-08 Sanofi Synthelabo Compositions pharmaceutiques pour administration transdermique d'agents anti-inflammatoires
JP4450545B2 (ja) * 2001-07-05 2010-04-14 ロート製薬株式会社 エアゾール製剤
GB0218996D0 (en) * 2002-08-14 2002-09-25 Novartis Ag Organic compounds
ME00420B (me) * 2003-03-20 2011-12-20 Boehringer Ingelheim Pharmaceuticals Inc Formulacija, za inhalator u kojem se odmjerava doza, u kojoj se kao propelenti koriste hidro-fluoro-alkani
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
BRPI0415725A (pt) * 2003-10-23 2006-12-19 Cipla Ltd formulação aspergìvel transdérmica, método para administrar um agente farmaceuticamente ativo e método para formar uma pelìcula farmaceuticamente ativa

Also Published As

Publication number Publication date
KR20080045272A (ko) 2008-05-22
IL190174A0 (en) 2008-08-07
AU2006290487A1 (en) 2007-03-22
JP2013067651A (ja) 2013-04-18
NO20081790L (no) 2008-06-11
GB0518769D0 (en) 2005-10-19
CA2622624A1 (en) 2007-03-22
PT1931310E (pt) 2012-09-12
BRPI0616061A2 (pt) 2011-06-07
CN101304730A (zh) 2008-11-12
JP2009507911A (ja) 2009-02-26
JP5677720B2 (ja) 2015-02-25
EP1931310A2 (en) 2008-06-18
RU2008114352A (ru) 2009-10-20
PL1931310T3 (pl) 2012-11-30
US8349297B2 (en) 2013-01-08
EP1931310B1 (en) 2012-06-06
CN101304730B (zh) 2011-01-19
KR101326207B1 (ko) 2013-11-11
WO2007031753A3 (en) 2007-06-07
RU2428970C2 (ru) 2011-09-20
ZA200803150B (en) 2009-06-24
CA2622624C (en) 2013-10-29
AU2006290487B2 (en) 2012-06-28
ES2391782T3 (es) 2012-11-29
US20090191271A1 (en) 2009-07-30
WO2007031753A2 (en) 2007-03-22
UA94917C2 (ru) 2011-06-25
NO339113B1 (no) 2016-11-14
IL190174A (en) 2015-06-30
NZ567022A (en) 2011-06-30
SI1931310T1 (sl) 2012-10-30

Similar Documents

Publication Publication Date Title
IL247484A0 (en) Gel preparations for local administration
GB0524962D0 (en) Topical pharmaceutical compositions
IL190174A0 (en) Topical film-forming monophasic formulations
DK2131813T3 (da) Topiske, farmaceutiske formuleringer
LTPA2018005I1 (lt) Farmacinė kompozicija
RU2398586C3 (ru) Фармацевтическая композиция
BRPI0511900A (pt) composições farmacêuticas
BRPI0715712A2 (pt) Composição farmacêutica
HUE052378T2 (hu) Lokális topikális adagolású, indoxacarb tartalmú formulációk
BRPI0719393A2 (pt) Composição farmacêutica
CY2014030I1 (el) Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate
BRPI0721651A2 (pt) Composição farmacêutica
BRPI0810928A2 (pt) "composição farmacêutica"
NO20075628L (no) Farmasøytiske formuleringer
DK1940467T3 (da) Lægemiddelsammensætning med langvarig frigivelse
BRPI0720234A2 (pt) Composição farmacêutica
DK2120884T3 (da) Farmaceutisk sammensætning
DK1725218T3 (da) Farmaceutisk sammensætning omfattende pimobendan
PT2209464E (pt) Composição farmacêutica antimalárica
DK3072507T3 (da) Farmaceutiske sammensætninger til glukokortikoidsubstitutionsterapi
ATE453384T1 (de) Neue dosierformulierung
DK1888024T3 (da) Topiske sammensætninger
EP2097074A4 (en) TOPICAL PHARMACEUTICAL COMPOSITION
DK2158908T3 (da) Sammensætning til transdermal administrering
BRPI0614413A2 (pt) composto, e, composição farmacêutica